Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWAMK is an active metabolite of the neurohormone melatonin (Item No. 14427).1,2,3,4 It is formed from melatonin via the metabolic intermediate AFMK (Item No. 10005254) that is then deformylated by catalase or formamidase.5,6 AMK scavenges singlet oxygen in vitro when used at a concentration of 200 µM.1 It inhibits the epinephrine- and arachidonic acid-induced production of prostaglandin E2 (PGE2; Item No. 14010) and PGD2 (Item No. 12010) in ovine seminal vesicle microsomes in a concentration- and time-dependent manner, as well as LPS-induced increases in COX-2 levels in RAW 264.7 macrophages when used at a concentration of 500 µM.2,3 AMK (20 mg/kg) decreases MPTP-induced increases in lipid peroxidation in the cytosol and mitochondria from substantia nigra and striatum in a mouse model of MPTP-induced Parkinson’s disease.4
WARNING This product is not for human or veterinary use.
1. The melatonin metabolite N1-
2. N-
3. Anti-
4. Melatonin and its brain metabolite N1-
5. Melatonin directly scavenges hydrogen peroxide: A potentially new metabolic pathway of melatonin biotransformation. Free Radic. Biol. Med. 29(11), 1177-1185 (2000).
6. In vitro and in vivo formation of two new metabolites of melatonin. The Journal of Biological Chemisty 249(4), 1311-1313 (1974).